Delivery Order SPE2DR25D1202-SPE2DR26F73LP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units) valued at $2,137.68. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by December 19, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Nucynta ER 150 mg tablets (60-count units) with a ceiling value of $6,598.58 and an ultimate completion date of December 1, 2025. This is a non-set-aside competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,312.52 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 50 mg tablets (60 count) on December 2, 2025, with a completion date of December 3, 2025. This was a competitively awarded, firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Nucynta ER 100 mg tablets (60-count) with a ceiling value of $1,400.62. This competitive, non-set-aside delivery order represents a firm fixed price contract with an ultimate completion date of August 27, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units) with a ceiling value of $1,425.14. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract is set to be completed by November 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units) valued at $1,181.68 under a firm fixed-price contract. This award represents a non-set-aside, competitively awarded delivery order with a completion date of September 29, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Nucynta ER 100 mg tablets in quantities of 60 units. This is a firm fixed price delivery order valued at $4,275.36 with an ultimate completion date of December 4, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Nucynta 100 mg tablets (100 count) with a contract ceiling value of $1,847.38. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and is scheduled for completion by November 18, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $7,119.13 to supply Nucynta ER (extended-release) 150mg tablets, with delivery expected by December 15, 2025. This firm fixed-price delivery order, awarded on December 12, 2025, represents a competitive procurement with no set-aside designation. The pharmaceutical products will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units) with a ceiling value of $1,472.04. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for ultimate completion on September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F73LPDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Nucynta ER 150 mg tablets (60-count units) with a contract value of $1,491.90. This competitively awarded, non-set-aside delivery order is classified as a firm fixed price contract and is scheduled for completion by December 30, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location in the same municipality. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support platform enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The DLA has designated AmerisourceBergen Drug Corp as a critical vendor within its Medical Supply Chain, allowing the company to fulfill federal procurement requirements for medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains in support of the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 12/28/25 |